Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13781461 | 0.85 | CYP11B1 (0.52) | ERN1EGFRKDRCYP17A1CYP11B1 | |
| SCHEMBL13781462 | 0.82 | CYP11B1 (0.49) | ERN1EGFRKDRCYP17A1CYP11B1 | |
| SCHEMBL13781463 | 0.81 | NPC1 (0.41) | — | |
| SCHEMBL28743751 | 0.78 | ERN1 (0.53) | ERN1EGFRKDRCYP17A1CYP11B1 | |
| SCHEMBL13781465 | 0.78 | TUBB4A (0.46) | EGFRKDRCYP17A1CYP11B1CYP11B2 | |
| SCHEMBL13781459 | 0.78 | TUBB4A (0.46) | EGFRKDRCYP17A1CYP11B1CYP11B2 | |
| SCHEMBL13781460 | 0.78 | TUBB4A (0.46) | EGFRKDRCYP17A1CYP11B1CYP11B2 | |
| SCHEMBL13781464 | 0.76 | ALDH1A1 (0.49) | KDRCHEK1ABL1 | |
| SCHEMBL13781458 | 0.76 | TDO2 (0.44) | EGFR | |
| SCHEMBL13781467 | 0.73 | ALDH1A1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090160315-A1 | ORGANIC ELECTROLUMINESCENCE MATERIAL AND ELEMENT USING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090160315-A1 | ORGANIC ELECTROLUMINESCENCE MATERIAL AND ELEMENT USING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090160315-A1 | ORGANIC ELECTROLUMINESCENCE MATERIAL AND ELEMENT USING THE SAME | RPL19, L1CAM, ELAVL1 | ERN1 1141/4885EGFR 637/4885KDR 884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.